Search Result "virological suppression."
Saquinavir/Ritonavir Monotherapy as a New Nucleoside-Sparing Maintenance Strategy in Long-Term Virologically Suppressed HIVInfected Patients
Journal: Current HIV Research
Volume: 8 Issue: 6 Year: 2010 Page: 467-470
Author(s): Patricia Echeverria, Pere Domingo, Mar Gutierrez, Mateo Gracia, Monse Fuster, Jose Molto, Jordi Puig, Nuria Perez-Alvarez, Bonaventura Clotet, Eugenia Negredo
Rates of Initial Virological Suppression and Subsequent Virological Failure After Initiating Highly Active Antiretroviral Therapy: The Impact of Aboriginal Ethnicity and Injection Drug Use
Journal: Current HIV Research
Volume: 8 Issue: 8 Year: 2010 Page: 649-658
Author(s): L. J. Martin, S. Houston, Y. Yasui, T. C. Wild, L. D. Saunders
Virological Suppression and Patterns of Resistance Amongst Patients on Antiretroviral Therapy at 4 Nigerian Military Hospitals
Journal: Current HIV Research
Volume: 15 Issue: 2 Year: 2017 Page: 146-151
Author(s): Keshinro Babajide,Ojor Ayemoba,Kene Terfa,Julie Ake,Trevor A. Crowell,Yakubu Adamu,Tahir Mohammed,Ifeanyi Okoye,Sunday Odeyemi,Keith Crawford,Lindsay Hughes,Ezekiel Akintunde,Tahir Umar,Tiffany E. Hamm,Ogbonnaya S. Njoku
Switching to Raltegravir in Virologically Suppressed in HIV-1-Infected Patients: A Retrospective, Multicenter, Descriptive Study
Journal: Current HIV Research
Volume: 10 Issue: 8 Year: 2012 Page: 673-678
Author(s): Daniel Podzamczer,Esteban Martinez,Pere Domingo,Elena Ferrer,Pompeyo Viciana,Jordi Curto,Maria-Jesus Perez-Elias,Antonio Ocampo,Ignacio Santos,Hernando Knobel,Vicente Estrada,Eugenia Negredo,Ferran Segura,Joaquin Portilla,Esteban Ribera,Josefa Galindo,Antonio Antela,Jorge Carmena,Manuel Castano,The TORAL Study Group
Antiretroviral Therapy-associated Adverse Drug Reactions and their Effects on Virologic Failure- A Retrospective Cohort Study in Nigeria
Journal: Current HIV Research
Volume: 16 Issue: 6 Year: 2018 Page: 436-446
Author(s): Isaac O. Abah,Nondumiso B.Q. Ncube,Hazel A. Bradley,Oche O. AgbaJi,Phyllis Kanki
Virology of SARS-CoV2
Ebook: An Update on SARS-CoV-2: Damage-response Framework, Potential Therapeutic Avenues and the Impact of Nanotechnology on COVID-19 Therapy Volume 1
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815039863122010005
Immunological and Virological Outcomes of Patients Switched from LPV/r to ATV/r-Containing Second- Line Regimens
Journal: Current HIV Research
Volume: 13 Issue: 3 Year: 2015 Page: 176-183
Author(s): A.S. Akanmu,T. Adeyemo,F. Lesi,F.O. Bello,K. Okwuegbuna,K. Oloko,A. Awolola,F.T. Ogunsola,P. Okonkwo,P.J. Kanki
Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected Patients
Journal: Current HIV Research
Volume: 15 Issue: 6 Year: 2017 Page: 448-455
Author(s): Serena Longo,Isabella Bon,Leonardo Calza,Giuseppina Musumeci,Alessia Bertoldi,Vanessa D`Urbano,Davide Gibellini,Eleonora Magistrelli,Pier Luigi Viale,Maria Carla Re
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
Journal: Infectious Disorders - Drug Targets
Volume: 11 Issue: 2 Year: 2011 Page: 167-174
Author(s): Jean B. Nachega, Vincent C. Marconi, Gert U. van Zyl, Edward M. Gardner, Wolfgang Preiser, Steven Y. Hong, Edward J. Mills, Robert Gross
Recent Developments in the Virology and Antiviral Research of Severe Acute Respiratory Syndrome Coronavirus
Journal: Infectious Disorders - Drug Targets
Volume: 7 Issue: 1 Year: 2007 Page: 29-41
Author(s): Kap-Sun Yeung, Nicholas A. Meanwell